Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 1 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 8/30/2012 10:29:51 AM : Outperform Start Price: $4.43 ALXA Score: +8.71

Perhaps early, but I want to be in this biotech the next 2-4 months

Featured Broker Partners


Advertisement